These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24477666)

  • 21. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
    Kim M; Jeong S; Sagong M
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
    Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
    Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.
    Babiuch AS; Han M; Conti FF; Wai K; Silva FQ; Singh RP
    JAMA Ophthalmol; 2019 Jan; 137(1):38-46. PubMed ID: 30286219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
    Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
    Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.
    Scott IU; VanVeldhuisen PC; Oden NL; Ip MS; Blodi BA; Hartnett ME; Cohen G;
    Ophthalmology; 2011 Feb; 118(2):345-52. PubMed ID: 20926135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion.
    Moon J; Kim M; Sagong M
    Eye (Lond); 2016 Aug; 30(8):1084-90. PubMed ID: 27229707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).
    Fish GE
    Trans Am Ophthalmol Soc; 2008; 106():276-300. PubMed ID: 19277242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion.
    Ach T; Hoeh AE; Schaal KB; Scheuerle AF; Dithmar S
    Graefes Arch Clin Exp Ophthalmol; 2010 Feb; 248(2):155-9. PubMed ID: 19763601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.
    Higashiyama T; Sawada O; Kakinoki M; Sawada T; Kawamura H; Ohji M
    Acta Ophthalmol; 2013 Jun; 91(4):318-24. PubMed ID: 22132711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study.
    Epstein DL; Algvere PV; von Wendt G; Seregard S; Kvanta A
    Ophthalmology; 2012 Dec; 119(12):2587-91. PubMed ID: 22902212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.
    Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study.
    Epstein DL; Algvere PV; von Wendt G; Seregard S; Kvanta A
    Ophthalmology; 2012 Jun; 119(6):1184-9. PubMed ID: 22424833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of bevacizumab as the primary treatment for retinal vein occlusions.
    Figueroa MS; Contreras I; Noval S; Arruabarrena C
    Br J Ophthalmol; 2010 Aug; 94(8):1052-6. PubMed ID: 20679089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion.
    Ahmadi AA; Chuo JY; Banashkevich A; Ma PE; Maberley DA
    Can J Ophthalmol; 2009 Apr; 44(2):154-9. PubMed ID: 19491948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reading speed improvements in retinal vein occlusion after ranibizumab treatment.
    Suñer IJ; Bressler NM; Varma R; Lee P; Dolan CM; Ward J; Colman S; Rubio RG
    JAMA Ophthalmol; 2013 Jul; 131(7):851-6. PubMed ID: 23699977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion.
    Hoeh AE; Ruppenstein M; Ach T; Dithmar S
    Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1567-72. PubMed ID: 20596719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion.
    Moon SY; Cho KH; Woo SJ; Park SP; Kim YK
    Korean J Ophthalmol; 2018 Feb; 32(1):29-37. PubMed ID: 29376223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.
    Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X
    Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal bevacizumab combined with grid photocoagulation in recurrent macular edema secondary to retinal vein occlusion.
    Farese E; Cennamo G; Velotti N; Traversi C; Rinaldi M; De Crecchio G
    Eur J Ophthalmol; 2014; 24(5):761-70. PubMed ID: 24585424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.